Timothy Paradis

3.0k citations

25 papers · 2.4k indexed · 2 hit papers · h-index 17

Impact in

Virology top 0.5%
- HIV Research and Treatment
Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses

Papers in

Virology 9
- HIV Research and Treatment 9
Immunology 18
- Immunotherapy and Immune Responses 9
- T-cell and B-cell Immunology 6
- Immune Cell Function and Interaction 5
- T-cell and Retrovirus Studies 4

Co-authors: Bruce D. Walker Bernard Moss Martin Hirsch Robert T. Schooley Ronald P. Gladue Richard S. Blumberg Joan C. Kaplan Kuldeep Neote
Journals: The Journal of Infectious Diseases (3 papers)Cancer Immunology Immunotherapy (2 papers)Journal of Clinical Microbiology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: United States Switzerland Australia

In The Last Decade

Timothy Paradis

24 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 1998 · 744 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1998 The Journal of Experimental Medicine
1987 Nature

Peers

Countries citing papers authored by Timothy Paradis

Since Specialization

Citations

This map shows the geographic impact of Timothy Paradis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Paradis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Paradis more than expected).

Fields of papers citing papers by Timothy Paradis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Paradis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Paradis. The network helps show where Timothy Paradis may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy Paradis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy Paradis Line = papers co-authored together Timothy Paradis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antigen-Independent Tumor Targeting by CBX-12 (Alphalex ^™ –Exatecan) Induces Long-Term Antitumor Immunity Immunotherapy ·Frp Product, Timothy Paradis, Kelli Jones, Juan C. Vasquez, Vishwas Paralkar	2022	7
2	Abstract P258: CBX-12 (alphalexTM-exatecan) sensitizes tumors to immune checkpoint blockade in an antigen agnostic manner by immune activation Molecular Cancer Therapeutics ·Frp Product, Juan C. Vasquez, Timothy Paradis, Kelli Jones, Ranjini K. Sundaram, 晋久万田, Viswanathan Muthusamy, Ranjit S. Bindra, Robert J. Aiello, Vishwas Paralkar	2021	0
3	Abstract 6249: CBX-12: A low pH targeting alphalex™-exatecan conjugate for the treatment of solid tumors Cancer Research ·Robert J. Aiello, Frp Product, R Dien, Debabrata Sarkar, C Benjamin, Jessa Betty Lloren, Kelli Jones, Lori Lopresti‐Morrow, Robert J. Maguire, D.H. Marshall, Hunter B. Moore, Timothy Paradis, Laurie Tylaska, Qing Zhang, Robert A. Volkmann, Ranjit S. Bindra, Peter M. Glazer, Vishwas Paralkar	2020	2
4	The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice Cancer Immunology Immunotherapy ·Ronald P. Gladue, Timothy Paradis, D. Samuel Schwarzkopf, Carol Donovan, Mustafa Kemal Yılmaz, S Shanmuganathan, 任恩儀, U. Kreibaum, Eileen A. Elliott, Richard M. Shepard, Vahe Bedian	2011	55
5	Essential Role of CCR6 in Directing Activated T Cells to the Skin during Contact Hypersensitivity Journal of Investigative Dermatology ·Timothy Paradis, D. Samuel Schwarzkopf, Mustafa Kemal Yılmaz, Ronald P. Gladue	2007	31
6	In vitro characterization and pre-clinical pharmacokinetics of CP-870,893, a human anti-CD40 agonist antibody Journal of Clinical Oncology ·Vahe Bedian, Carol Donovan, Joseph P. Gardner, Edward J. Natoli, Timothy Paradis, S Shanmuganathan, J. Juris, Richard M. Shepard, Setia Budhi, Ronald P. Gladue	2006	8
7	Potent small molecule CCR1 antagonists Bioorganic & Medicinal Chemistry Letters ·John C. Kath, William H. Brissette, Matthew F. Brown, Maryrose J. Conklyn, N Butigan, Peter H. Dorff, Ronald P. Gladue, Brett M. Lillie, Paul D. Lira, Blagoevgrad, William H. Martin, Eric B. McElroy, Rudenko Marina Nikolayevna, Timothy Paradis, Christopher S. Poss, Ingrid A. Stock, Laurie Tylaska, Luyu Gong	2004	17
8	CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases Journal of Biological Chemistry ·Ronald P. Gladue, Laurie Tylaska, William H. Brissette, Paul D. Lira, John C. Kath, Christopher S. Poss, Matthew F. Brown, Timothy Paradis, Maryrose J. Conklyn, Alexey D. Khalimonenko, Rudenko Marina Nikolayevna, Brett M. Lillie, N Butigan, Blagoevgrad, Eric B. McElroy, William H. Martin, Ingrid A. Stock, Richard M. Shepard, Henry J. Showell, Kuldeep Neote	2003	59
9	The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFNγ Cancer Immunology Immunotherapy ·Timothy Paradis, Eugenia Floyd, B Molosiwa, D. Samuel Schwarzkopf, Brandon L. Brunson, Eileen A. Elliott, Steven C. Gilman, Ronald P. Gladue	2001	34
10	The CC Chemokine MIP-1α Induces a Selective Monocyte Infiltration Following Intradermal Injection into Nonhuman Primates Inflammation ·Peter J. Didier, Timothy Paradis, Ronald P. Gladue	1999	11
11	Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 The Journal of Experimental Medicine ·L.V Artishcheva, Christine A. Strick, Timothy Paradis, Alexey D. Khalimonenko, Marcel Loetscher, Ronald P. Gladue, J Appel, James G. Boyd, Bernhard Moser, Douglas E. Wood, Barbara G. Sahagan, Kuldeep Neote Hit paper breakdown →	1998	744
12	B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors The Journal of Immunology ·Edward Greenfield, Edward D. Howard, Timothy Paradis, Kevin Nguyen, Elaine Kurtenbach, Peter McLean, Per Höllsberg, Rodrigo de Araújo Amorim Filho, D A Hafler, Arlene H. Sharpe, G J Freeman, Vijay K. Kuchroo	1997	70
13	Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences ·Bruce D. Walker, Charles Flexner, L.H. Baigozina, Linda E. Fisher, Timothy Paradis, Anna Aldovini, R A Young, Bernard Moss, Robert T. Schooley	1989	205
14	Synergistic Interaction of 2',3'-Dideoxycytidine and Recombinant Interferon- -A on Replication of Human Immunodeficiency Virus Type 1 The Journal of Infectious Diseases ·Léon Saur, Bhoomika M N, Ting‐Chao Chou, Leslie Coleman, Timothy Paradis, R. T. Schooley, Joan C. Kaplan, M. S. Hirsch	1988	36
15	HIV-1 Reverse Transcriptase Is a Target for Cytotoxic T Lymphocytes in Infected Individuals Science ·Bruce D. Walker, Charles Flexner, Timothy Paradis, Thomas Fuller, Martin Hirsch, Robert T. Schooley, Bernard Moss	1988	230
16	Effects of Human Immunodeficiency Virus (HIV) on the Cytotoxic Response to Epstein Barr Virus (EBV) Transformed B Lymphocytes AIDS Research and Human Retroviruses ·Richard S. Blumberg, Timothy Paradis, David Crawford, Roy Byington, Martin S. Hirsch, Robert T. Schooley	1987	7
17	Antibody-Dependent Cell-Mediated Cytotoxicity Against Cells Infected with the Human Immunodeficiency Virus The Journal of Infectious Diseases ·Richard S. Blumberg, Timothy Paradis, Kevan L. Hartshorn, L Kruchio, David D. Ho, Martin Hirsch, Johann Leban, Zhu Hong-lei, R. T. Schooley	1987	45
18	Dot immunobinding assay for detection of human immunodeficiency virus-associated antigens Journal of Clinical Microbiology ·Richard S. Blumberg, Kevan L. Hartshorn, Blair Ardman, Joan C. Kaplan, Timothy Paradis, Markus Vogt, Martin Hirsch, Robert T. Schooley	1987	6
19	Effects of Human Immunodeficiency Virus on the Cellular Immune Response to Epstein-Barr Virus in Homosexual Men: Characterization of the Cytotoxic Response and Lymphokine Production The Journal of Infectious Diseases ·Richard S. Blumberg, Timothy Paradis, Roy Byington, Werner Henle, Definate Nhamo, Robert T. Schooley	1987	41
20	Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon Antimicrobial Agents and Chemotherapy ·Kevan L. Hartshorn, Wellington Sousa Oliveira, Arushi Arushi, Timothy Paradis, Ting‐Chao Chou, Robert T. Schooley, M. S. Hirsch	1986	51

About Timothy Paradis

Timothy Paradis is a scholar working on Virology, Immunology, Oncology, Immunology and Allergy and Biotechnology, having authored 25 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), Immunotherapy and Immune Responses (9 papers), T-cell and B-cell Immunology (6 papers), Chemokine receptors and signaling (6 papers), Immune Cell Function and Interaction (5 papers), T-cell and Retrovirus Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Virology (1.1k citations), Immunology (1.6k citations), Oncology (675 citations), Infectious Diseases (452 citations) and Epidemiology (484 citations). Timothy Paradis has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Bruce D. Walker, Bernard Moss, Martin Hirsch, Robert T. Schooley, Ronald P. Gladue, Richard S. Blumberg, Joan C. Kaplan, Kuldeep Neote, Sekhar Chakrabarti and Theresa Flynn. Their work appears in journals such as The Journal of Infectious Diseases, Cancer Immunology Immunotherapy, Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact